Reviva Pharmaceuticals (RVPH) Competitors $1.01 -0.08 (-7.34%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$1.06 +0.05 (+5.05%) As of 03/28/2025 07:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RVPH vs. ZNTL, ACTU, OGI, DERM, ALEC, SAVA, LXEO, TELO, PRQR, and GNLXShould you be buying Reviva Pharmaceuticals stock or one of its competitors? The main competitors of Reviva Pharmaceuticals include Zentalis Pharmaceuticals (ZNTL), Actuate Therapeutics (ACTU), Organigram (OGI), Journey Medical (DERM), Alector (ALEC), Cassava Sciences (SAVA), Lexeo Therapeutics (LXEO), Telomir Pharmaceuticals (TELO), ProQR Therapeutics (PRQR), and Genelux (GNLX). These companies are all part of the "pharmaceutical products" industry. Reviva Pharmaceuticals vs. Zentalis Pharmaceuticals Actuate Therapeutics Organigram Journey Medical Alector Cassava Sciences Lexeo Therapeutics Telomir Pharmaceuticals ProQR Therapeutics Genelux Zentalis Pharmaceuticals (NASDAQ:ZNTL) and Reviva Pharmaceuticals (NASDAQ:RVPH) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, institutional ownership, analyst recommendations, community ranking, profitability, risk and earnings. Which has better earnings and valuation, ZNTL or RVPH? Reviva Pharmaceuticals has lower revenue, but higher earnings than Zentalis Pharmaceuticals. Reviva Pharmaceuticals is trading at a lower price-to-earnings ratio than Zentalis Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioZentalis Pharmaceuticals$40.56M3.18-$292.19M-$2.49-0.73Reviva PharmaceuticalsN/AN/A-$39.26M-$1.11-0.91 Does the media refer more to ZNTL or RVPH? In the previous week, Zentalis Pharmaceuticals had 9 more articles in the media than Reviva Pharmaceuticals. MarketBeat recorded 12 mentions for Zentalis Pharmaceuticals and 3 mentions for Reviva Pharmaceuticals. Reviva Pharmaceuticals' average media sentiment score of 1.44 beat Zentalis Pharmaceuticals' score of 0.54 indicating that Reviva Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Zentalis Pharmaceuticals 1 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Reviva Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals believe in ZNTL or RVPH? 63.2% of Reviva Pharmaceuticals shares are owned by institutional investors. 3.6% of Zentalis Pharmaceuticals shares are owned by insiders. Comparatively, 27.2% of Reviva Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has more volatility & risk, ZNTL or RVPH? Zentalis Pharmaceuticals has a beta of 1.75, indicating that its stock price is 75% more volatile than the S&P 500. Comparatively, Reviva Pharmaceuticals has a beta of -0.09, indicating that its stock price is 109% less volatile than the S&P 500. Is ZNTL or RVPH more profitable? Reviva Pharmaceuticals' return on equity of 0.00% beat Zentalis Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Zentalis PharmaceuticalsN/A -43.91% -34.96% Reviva Pharmaceuticals N/A N/A -252.53% Do analysts rate ZNTL or RVPH? Zentalis Pharmaceuticals presently has a consensus price target of $8.24, suggesting a potential upside of 355.49%. Reviva Pharmaceuticals has a consensus price target of $11.40, suggesting a potential upside of 1,028.71%. Given Reviva Pharmaceuticals' stronger consensus rating and higher probable upside, analysts clearly believe Reviva Pharmaceuticals is more favorable than Zentalis Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Zentalis Pharmaceuticals 0 Sell rating(s) 5 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.44Reviva Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 2 Strong Buy rating(s) 3.29 Does the MarketBeat Community believe in ZNTL or RVPH? Zentalis Pharmaceuticals received 35 more outperform votes than Reviva Pharmaceuticals when rated by MarketBeat users. However, 90.00% of users gave Reviva Pharmaceuticals an outperform vote while only 62.00% of users gave Zentalis Pharmaceuticals an outperform vote. CompanyUnderperformOutperformZentalis PharmaceuticalsOutperform Votes6262.00% Underperform Votes3838.00% Reviva PharmaceuticalsOutperform Votes2790.00% Underperform Votes310.00% SummaryReviva Pharmaceuticals beats Zentalis Pharmaceuticals on 11 of the 17 factors compared between the two stocks. Remove Ads Get Reviva Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RVPH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RVPH vs. The Competition Export to ExcelMetricReviva PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$33.78M$6.90B$5.63B$7.84BDividend YieldN/A2.76%5.33%4.01%P/E Ratio-0.917.2623.5518.73Price / SalesN/A218.61388.1990.75Price / CashN/A65.6738.1734.64Price / Book5.056.386.894.23Net Income-$39.26M$142.34M$3.20B$247.47M7 Day Performance-2.88%-5.15%-3.06%-2.29%1 Month Performance-29.86%-7.55%1.51%-5.81%1 Year Performance-73.28%-11.06%9.37%-0.96% Reviva Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RVPHReviva Pharmaceuticals4.2151 of 5 stars$1.01-7.3%$11.40+1,028.7%-73.3%$33.78MN/A-0.915Short Interest ↓News CoverageZNTLZentalis Pharmaceuticals1.9268 of 5 stars$1.98+3.7%$8.24+316.4%-88.5%$141.11M$40.56M-0.80160Earnings ReportUpcoming EarningsAnalyst ForecastAnalyst RevisionNews CoverageGap DownACTUActuate TherapeuticsN/A$7.20+6.7%$20.00+177.8%N/A$140.63MN/A0.0010Gap DownOGIOrganigram0.6888 of 5 stars$1.11flatN/A-52.1%$140.10M$166.12M-2.92860DERMJourney Medical2.5215 of 5 stars$6.54+13.9%$9.67+47.8%+66.0%$136.62M$57.77M-6.9690Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageHigh Trading VolumeALECAlector3.8025 of 5 stars$1.37+1.5%$3.50+155.5%-78.6%$135.75M$100.56M-0.81270SAVACassava Sciences3.8715 of 5 stars$2.80-1.4%$111.50+3,882.1%-91.9%$135.26MN/A-2.0330Analyst ForecastShort Interest ↓LXEOLexeo Therapeutics3.3152 of 5 stars$4.09+50.9%$23.60+477.0%-73.9%$135.24M$650,000.00-1.2958Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageHigh Trading VolumeTELOTelomir Pharmaceuticals2.3644 of 5 stars$4.53-0.7%$15.00+231.1%-23.3%$134.83MN/A-7.811Gap DownPRQRProQR Therapeutics1.9366 of 5 stars$1.65flat$9.50+475.8%-38.9%$134.77M$18.91M-5.16180Analyst RevisionPositive NewsGap UpGNLXGenelux1.4428 of 5 stars$3.89-1.0%$18.25+369.2%-52.1%$134.35M$8,000.00-4.0910Earnings ReportUpcoming EarningsAnalyst ForecastAnalyst RevisionNews Coverage Remove Ads Related Companies and Tools Related Companies ZNTL Alternatives ACTU Alternatives OGI Alternatives DERM Alternatives ALEC Alternatives SAVA Alternatives LXEO Alternatives TELO Alternatives PRQR Alternatives GNLX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RVPH) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersTrump's 100-Day Plan Triggers Global RetaliationIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredWall Street’s “AI Oracle” Reveals Next Big Tech PlayA tiny American tech company could be at the center of the next big AI breakthrough. Wall Street's "AI Orac...InvestorPlace | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredCrypto Genius: 12,000% in 12 months? [Here’s how]We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredForget Trump’s Tariffs, This March Event Is BiggerWhile everyone is distracted by Trump’s tariffs and a potential trade war… There’s something much bigger ha...Brownstone Research | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reviva Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Reviva Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
